Reacto and immunogenicity of an inactivated hepatitis A vaccine in children with chronic renal disease.

被引：0
|
作者：
Velasco, MCC
Mutti, J
Alvarez, K
Palti, G
Gonzalez, J
Exeni, R
Rüttimann, R
机构：
[1] Hosp Nino San Justo, Buenos Aires, DF, Argentina
[2] Inst Malbran, Buenos Aires, DF, Argentina
[3] GlaxoSmithKline, Buenos Aires, DF, Argentina
来源：
HEPATOLOGY | 2002年 / 36卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1950
引用
收藏
页码：650A / 650A
页数：1
相关论文
共 50 条
  • [21] Safety and immunogenicity of a new formulation of an inactivated hepatitis A vaccine
    Dagan, R
    Greenberg, D
    Goldenbertg-Gehtman, P
    Vidor, E
    Briantais, P
    Pinsk, V
    Athias, O
    Dumas, R
    VACCINE, 1999, 17 (15-16) : 1919 - 1925
  • [22] IMMUNOGENICITY OF AN INACTIVATED HEPATITIS-A VACCINE IN ALASKA NATIVE CHILDREN AND NATIVE AND NONNATIVE ADULTS
    MCMAHON, BJ
    WILLIAMS, J
    BULKOW, L
    SNOWBALL, M
    WAINWRIGHT, R
    KENNEDY, M
    KRAUSE, D
    JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (03): : 676 - 679
  • [23] SAFETY AND IMMUNOGENICITY OF AN INACTIVATED HEPATITIS-A VIRUS-VACCINE IN PRESCHOOL-CHILDREN
    BALCAREK, KB
    BAGLEY, MR
    PASS, RF
    KRAUSE, D
    CLINICAL RESEARCH, 1993, 41 (04): : A766 - A766
  • [24] Safety and immunogenicity of hepatitis A vaccine in patients with chronic liver disease
    Keeffe, EB
    Iwarson, S
    McMahon, BJ
    Lindsay, KL
    Koff, RS
    Manns, M
    Baumgarten, R
    Wiese, M
    Fourneau, M
    Safary, A
    Clemens, R
    Krause, DS
    HEPATOLOGY, 1998, 27 (03) : 881 - 886
  • [25] Immunogenicity of an inactivated hepatitis A vaccine in Dutch United Nations troops
    Buma, APCCH
    vanDoornum, GJJ
    Veltink, RL
    vanAmeijden, EJC
    LeentvaarKuijpers, A
    Coutinho, RA
    VACCINE, 1997, 15 (12-13) : 1413 - 1417
  • [26] Long-term immunogenicity of an inactivated virosome hepatitis A vaccine
    Bovier, PA
    Bock, J
    Loutan, L
    Farinelli, T
    Glueck, R
    Herzog, C
    JOURNAL OF MEDICAL VIROLOGY, 2002, 68 (04) : 489 - 493
  • [27] Safety, immunogenicity and antibody persistence of an inactivated hepatitis A vaccine in 4 to 15 year old children
    de Febres, OC
    de Petrola, MC
    de Escalona, LC
    Naveda, O
    Naveda, M
    Estopinan, M
    Bordones, G
    Zambrano, B
    Garcia, A
    Dumas, R
    VACCINE, 1999, 18 (7-8) : 656 - 664
  • [28] Immunogenicity of hepatitis a vaccine in children with cancer
    Koksal, Yavuz
    Yalcin, Bilgehan
    Aydin, Burca
    Sari, Neriman
    Yazici, Nalan
    Varan, Ali
    Kutluk, Tezer
    Akyuz, Canan
    Buyukpamukcu, Munevver
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2006, 23 (08) : 619 - 624
  • [29] Hepatitis B virus vaccine and chronic kidney disease. The advances
    Fabrizi, Fabrizio
    Cerutti, Roberta
    Dixit, Vivek
    Ridruejo, Ezequiel
    NEFROLOGIA, 2021, 41 (02): : 115 - 122
  • [30] Immunogenicity and safety of an inactivated hepatitis a vaccine administered concomitantly with a pneumococcal conjugate vaccine in healthy children 15 months of age
    Trofa, Andrew F.
    Levin, Michael
    Marchant, Colin D.
    Hedrick, James
    Blatter, Mark M.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2008, 27 (07) : 658 - 660
12345